State Street’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-43,283
Closed -$254K 4479
2023
Q4
$254K Sell
43,283
-1,349
-3% -$16K ﹤0.01% 3839
2023
Q3
$1.13M Sell
44,632
-16
-0% -$1.31K ﹤0.01% 3497
2023
Q2
$6.21M Sell
44,648
-773
-2% -$99.2K ﹤0.01% 2895
2023
Q1
$4.13M Buy
45,421
+1,498
+3% +$203K ﹤0.01% 3064
2022
Q4
$6.02M Buy
43,923
+9,766
+29% +$3.31M ﹤0.01% 2960
2022
Q3
$29.6M Buy
34,157
+564
+2% +$354K ﹤0.01% 1946
2022
Q2
$14.7M Buy
33,593
+22,933
+215% +$12M ﹤0.01% 2460
2022
Q1
$6.77M Buy
10,660
+1,176
+12% +$741K ﹤0.01% 3033
2021
Q4
$8.45M Buy
9,484
+4,329
+84% +$4.55M ﹤0.01% 3002
2021
Q3
$6.54M Buy
+5,155
New +$6.25M ﹤0.01% 3095

Other funds holding CANO

State Street's CANO Position: Q1 2024 in Review

State Street sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 43,283 shares — an estimated $254K sold.

State Street first reported a position in CANO in Q3 2021 and held it in 10 quarters. The position peaked at $29.6M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • State Street reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • State Street sold 43,283 Cano Health, Inc. shares in Q1 2024, an estimated $254K.
  • State Street first reported a position in Cano Health, Inc. in Q3 2021 and held it in 10 quarters.
  • State Street's Cano Health, Inc. position peaked at $29.6M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.